End-organ susceptibility as a determinant of renal disease in hypertension

被引：6
|
作者：
Raij, L
Madias, NE
Lenz, O
Epstein, M
Jaimes, EA
Materson, BJ
Banerjee, D
Preston, RA
Roth, D
Abraira, C
机构：
[1] Vet Affairs Med Ctr, Nephrol Hypertens Div, Nephrol Hypertens Sect, Miami, FL 33125 USA
[2] Univ Miami, Sch Med, Nephrol Hypertens Div, Miami, FL USA
[3] Univ Miami, Sch Med, Vasc Biol Inst, Miami, FL USA
[4] Tufts Univ, Sch Med, Boston, MA 02111 USA
[5] Univ Miami, Sch Med, Div Nephrol, Coral Gables, FL 33124 USA
[6] Univ Miami, Sch Med, Vet Affairs Med Ctr, Nephrol Sect, Coral Gables, FL 33124 USA
[7] Univ Miami, Sch Med, Nephrol Hypertens Div, Coral Gables, FL 33124 USA
[8] Univ Miami, Sch Med, Div Clin Pharmacol, Coral Gables, FL 33124 USA
[9] Univ Miami, Sch Med, Div Endocrinol, Coral Gables, FL 33124 USA
来源：
KIDNEY INTERNATIONAL | 2003年 / 64卷 / 05期
关键词：
glomerular hypertension; preglomerular resistance; angiotensin II; nitric oxide; vascular remodeling;
D O I：
10.1046/j.1523-1755.2003.00291.x
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1923 / 1932
页数：10
相关论文
共 50 条
  • [31] Ambulatory Hypertension in Pediatric Patients With Sickle Cell Disease and Its Association With End-Organ Damage
    Ranabothu, Saritha
    Hafeman, Michael
    Manwani, Deepa
    Reidy, Kimberly
    Morrone, Kerry
    Lorenzo, Josemiguel
    Tria, Barbara
    Kaskel, Frederick
    Mahgerefteh, Joseph
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (11)
  • [32] Reduced hypertension-induced end-organ damage in mice lacking cardiac and renal angiotensinogen synthesis
    Kang, NL
    Walther, T
    Tian, XL
    Bohlender, J
    Fukamizu, A
    Ganten, D
    Bader, M
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2002, 80 (06): : 359 - 366
  • [33] Activation of PPAR-alpha reduces cardiac and renal end-organ damage in salt sensitive hypertension
    Sandner, P.
    Klein, M.
    Albrecht, B.
    Hartmann, E.
    Schaefer, S.
    Huetter, J.
    EUROPEAN HEART JOURNAL, 2006, 27 : 479 - 479
  • [34] Endothelin blockers and renal protection: a new strategy to prevent end-organ damage in cardiovascular disease?
    Rabelink, TJ
    Stroes, ESG
    Bouter, KP
    Morrison, P
    CARDIOVASCULAR RESEARCH, 1998, 39 (03) : 543 - 549
  • [35] Consideration of hypertensive retinopathy as an important end-organ damage in patients with hypertension
    Kolman, S. A. M.
    van Sijl, A. M.
    van der Sluijs, F. A.
    van de Ree, M. A.
    JOURNAL OF HUMAN HYPERTENSION, 2017, 31 (02) : 121 - 125
  • [36] Hyperinsulinemia, circadian variation of blood pressure and end-organ damage in hypertension
    Bianchi, S
    Bigazzi, R
    Nenci, R
    Campese, VM
    JOURNAL OF NEPHROLOGY, 1997, 10 (06) : 325 - 333
  • [37] A new evidence of end-organ damage in the patients with arterial hypertension: Epistaxis?
    Celik, Turgay
    Iyisoy, Atila
    Yuksel, Uygar Cagdas
    Karahatay, Serdar
    Tan, Yalcin
    Isik, Ersoy
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 141 (01) : 105 - 107
  • [38] PSYCHOPHYSIOLOGICAL REACTIVITY AND CARDIAC END-ORGAN CHANGES IN WHITE COAT HYPERTENSION
    CARDILLO, C
    DEFELICE, F
    CAMPIA, U
    FOLLI, G
    HYPERTENSION, 1993, 21 (06) : 836 - 844
  • [39] Consideration of hypertensive retinopathy as an important end-organ damage in patients with hypertension
    S A M Kolman
    A M van Sijl
    F A van der Sluijs
    M A van de Ree
    Journal of Human Hypertension, 2017, 31 : 121 - 125
  • [40] Cognitive disorders and dementia - new end-organ damage due to hypertension
    Trenkwalder, P
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2000, 125 (45) : 1349 - 1349
12345